Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Smoking Cessation × Amyloid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 3 Urinary Bladder Neoplasms 1 Tobacco Use Disorder 1 Sunburn 1 Stress, Psychological 1 Stress Disorders, Post-Traumatic 1 Smoking Cessation 1 Sarcoma 1 Prostatic Hyperplasia 1 Motor Activity 1 Melanoma 1 Lymphoma, Non-Hodgkin 1 Hodgkin Disease 1 Head and Neck Neoplasms 1 Esophageal Neoplasms 1 Digestive System Abnormalities 1 Depression 1 Central Nervous System Neoplasms 1 Anxiety Disorders 1 Alzheimer Disease 1 Acquired Immunodeficiency Syndrome 1

Interventions

Tobacco Use Cessation Devices 11 Varenicline 9 Surveys and Questionnaires 8 Nicotine Replacement Therapy 7 Standard of Care 4 Motivational Interviewing 4 Preoperative Exercise 3 Methods 3 Ethanol 3 Videotape Recording 2 Tomography, X-Ray Computed 2 Tobacco Products 2 Smoking Devices 2 Secondary Prevention 2 Nicotine Chewing Gum 2 Mindfulness 2 Interviews as Topic 2 Hematologic Tests 2 Focus Groups 2 Cognitive Behavioral Therapy 2 Carbon Monoxide 2 Bupropion 2 Aspirin 2 thiamine triphosphorate 1 sulforaphane 1 polyphenon E 1 cytisine 1 Yoga 1 Urinalysis 1 Transdermal Patch 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06883097 2025-12-17

QMH

Wake Forest University Health Sciences

Phase NA Recruiting

Acquired Immunodeficiency Syndrome, Tobacco Use Disorder, Smoking Cessation

Data powered by HemOnc (CC BY 4.0) Colophon ⚡